FAK-deficiency not only prevented the physical interaction between β3 integrin and TβR-II, but also abrogated oncogenic signaling by TGF-β and its ability to induce EMT, invasion, and systemic dissemination of breast cancer cells. The gene discussed is TGFBR2; the disease is breast carcinoma.